Skin News and Research

RSS

New portable shield prevents spread of saliva and aerosols generated during dental procedures

Dental treatments are performed at close proximity to the mouths and noses of the patients, and the procedures are often related to the generation of aerosols as well as handling of oral fluids and blood. This puts dentists at a high risk of exposure to COVID-19, and other critical infectious diseases.

21 Dec 2020

Researchers develop a method to examine the body’s own pain control system

When two painful stimuli act on us at the same time, we perceive the one of them as less painful. This phenomenon is part of the body’s own pain control system.

21 Dec 2020

Allergic diseases are more common among dogs and their owners in urban environments

In urban environments, allergic diseases are more common among dogs and their owners compared to those living in rural areas.

20 Dec 2020

Invirsa signs license agreement with AWRI to expand treatment platform for respiratory diseases

Invirsa, a Columbus-based pharmaceutical company, today announced execution of a license agreement with the Abigail Wexner Research Institute (AWRI) at Nationwide Children's Hospital as Invirsa seeks to broaden its treatment platform to address respiratory diseases.

20 Dec 2020

FDA approves first adjuvant treatment for patients with non-small cell lung cancer

Today, the U.S. Food and Drug Administration approved Tagrisso (osimertinib) as the first adjuvant treatment for patients with non-small cell lung cancer whose tumors have a specific type of genetic mutation.

18 Dec 2020

FDA approves first implant system for adults who have above-the-knee amputations

The U.S. Food and Drug Administration today approved the Osseoanchored Prostheses for the Rehabilitation of Amputees (OPRA) Implant System, the first implant system marketed in the U.S. for adults who have transfemoral—or above-the-knee—amputations and who have or are anticipated to have rehabilitation problems with, or cannot use, a conventional socket prosthesis.

18 Dec 2020

FDA approves first oral drug for treating adult patients with advanced prostate cancer

Today, the U.S. Food and Drug Administration approved Orgovyx (relugolix) for the treatment of adult patients with advanced prostate cancer.

18 Dec 2020

Very few COVID-19-positive children require hospitalization, finds case study

A team of researchers at the Divisions of Infectious Diseases, UPMC Children’s Hospital of Pittsburgh and the University of Pittsburgh, USA, sought to characterize the clinical presentation of children with COVID-19 in Western Pennsylvania.

18 Dec 2020

Cell atlas helps better understand the biology of tropical disease parasite

The first cell atlas of an important life stage of Schistosoma mansoni, a parasitic worm that poses a risk to hundreds of millions of people each year, has been developed by researchers at the Wellcome Sanger Institute and their collaborators.

18 Dec 2020

Researchers develop a technique to predict epileptic seizures

A third of epilepsy sufferers are resistant to treatment for this neurological disease that affects 1% of the population.

18 Dec 2020

COVID-19 pandemic highlights the risk of using systemic corticosteroids

Healthcare workers in tropical and sub-tropical settings where strongyloidiasis is prevalent or caring for patients who have travelled to such areas, need to maintain a high level of awareness about the use of corticosteroids, including when this class of anti-inflammatories is given to patients suspected of infection with SARS-CoV-2.

17 Dec 2020

A protein may be responsible for triggering lung scarring in scleroderma patients

Systemic sclerosis is an autoimmune disease associated with inflammation and fibrosis, or scarring, that affects organs including the skin, heart, kidney and lungs.

17 Dec 2020

Skin cancer risk remains high in winter months for college students

New research from Brigham Young University finds college students could be just as at risk for developing skin cancer in the dead of winter as they are in the middle of summer.

17 Dec 2020

Scientists examine the virulent potential of Listeria strains in pigs

Researchers from the CEU Cardenal Herrera University (CEU UCH) of Valencia, the University of Cordoba and the Pasteur Institute of Paris, have conducted a study to determine the virulent potential of strains of the Listeria monocytogenes bacteria in pigs in Spain.

17 Dec 2020

LOOP technique is an effective alternative for treating skin abscesses

The LOOP technique for incision and drainage (I&D) of abscesses in adults is a safe and effective alternative to the traditional I & D with packing and may offer an alternative to the standard regimen in the treatment of uncomplicated skin abscesses in pediatric patients.

17 Dec 2020

FAT1 mutations act as tumor suppressor and prevent cancer development, indicates study

Cancer metastasis, which is the dissemination of tumor cells into distant organs, is the leading cause of mortality in cancer patients. To undergo metastasis, cells must leave the primary tumor, circulate into the blood, colonize distant organs, and form distant metastasis.

17 Dec 2020

Researchers use new method to deliver anti-cancer drug to suppress tumor growth

Targeting drugs to cancer tissues is a major challenge in cancer treatment. Mesenchymal stem cells (MSCs) are known for their ability to find and target tumor cells in the body, but using MSCs for drug delivery has been tricky, because upon loading with drugs, MSCs lose their viability and migratory ability.

17 Dec 2020

New study to evaluate health outcomes of SARS-CoV-2 infection in children

An observational study has launched to evaluate the short- and long-term health outcomes of SARS-CoV-2 infection in children, including multisystem inflammatory syndrome in children (MIS-C), and to characterize the immunologic pathways associated with different disease presentations and outcomes. SARS-CoV-2 is the virus that causes COVID-19.

16 Dec 2020

Using an evaporation-based approach to turn sweat against itself

Body odor is an unpleasant smell, produced when bacteria living on the skin break down the proteins in sweat.

16 Dec 2020

LRA survey: Two-thirds of people with lupus are willing to take COVID-19 vaccine

Two out of three people with lupus (64%) are willing to take a COVID-19 vaccine if it is free and determined safe by scientists according to results of a survey conducted by the Lupus Research Alliance.

16 Dec 2020

Skin News and Research

New portable shield prevents spread of saliva and aerosols generated during dental procedures

Researchers develop a method to examine the body’s own pain control system

Allergic diseases are more common among dogs and their owners in urban environments

Invirsa signs license agreement with AWRI to expand treatment platform for respiratory diseases

FDA approves first adjuvant treatment for patients with non-small cell lung cancer

FDA approves first implant system for adults who have above-the-knee amputations

FDA approves first oral drug for treating adult patients with advanced prostate cancer

Very few COVID-19-positive children require hospitalization, finds case study

Cell atlas helps better understand the biology of tropical disease parasite

Researchers develop a technique to predict epileptic seizures

COVID-19 pandemic highlights the risk of using systemic corticosteroids

A protein may be responsible for triggering lung scarring in scleroderma patients

Skin cancer risk remains high in winter months for college students

Scientists examine the virulent potential of Listeria strains in pigs

LOOP technique is an effective alternative for treating skin abscesses

FAT1 mutations act as tumor suppressor and prevent cancer development, indicates study

Researchers use new method to deliver anti-cancer drug to suppress tumor growth

New study to evaluate health outcomes of SARS-CoV-2 infection in children

Using an evaporation-based approach to turn sweat against itself

LRA survey: Two-thirds of people with lupus are willing to take COVID-19 vaccine

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News